Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
hPL-IN-1
Cat. No.:
OB0425LY-195
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
hPL-IN-1is a potent and reversible pancreatic lipase inhibitor.
Synonyms:
2387374-26-5; N-[3-Chloro-4-(4-chlorophenoxy)phenyl]-3,5-difluoro-2-hydroxybenzamide
CAS No.:
2387374-26-5
Compound CID:
153365335
Formula:
C19H11Cl2F2NO3
Formula Weight:
410.2
Specification
Target:
Lipase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
hPL-IN-1 can be used for anti-obesity research.
